Regresa al Registro Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorPrager, Gerald W
dc.contributor.authorWestphalen, C Benedikt
dc.contributor.authorD'Esquermes, Nathalie
dc.contributor.authorFerreras, Anabel
dc.contributor.authorMacarulla Mercadé, Teresa
dc.contributor.authorTaieb, Julien
dc.contributor.authorMelisi, Davide
dc.date.accessioned2021-10-22T05:44:42Z
dc.date.available2021-10-22T05:44:42Z
dc.date.issued2020-01-20
dc.identifier.citationTaieb J, Prager GW, Melisi D, Westphalen CB, D’Esquermes N, Ferreras A, et al. First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study. ESMO Open. 2020 Jan 20;5:e000587.
dc.identifier.issn2059-7029
dc.identifier.urihttps://hdl.handle.net/11351/6435
dc.descriptionEuropa oriental; Gemcitabina; Cáncer de páncreas
dc.language.isoeng
dc.publisherBMJ
dc.relation.ispartofseriesESMO Open;5
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectPàncrees - Càncer - Quimioteràpia
dc.subjectAdenocarcinoma - Quimioteràpia
dc.subject.meshPancreatic Neoplasms
dc.subject.meshAdenocarcinoma
dc.subject.mesh/drug therapy
dc.titleFirst-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1136/esmoopen-2019-000587
dc.subject.decsneoplasias pancreáticas
dc.subject.decsadenocarcinoma
dc.subject.decs/farmacoterapia
dc.relation.publishversionhttps://doi.org/10.1136/esmoopen-2019-000587
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Taieb J] Hôpital Européen Georges Pompidou, AP-HP, Paris, France. Sorbonne Paris Cité, Université Paris Descartes, Paris, France. [Prager GW] Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. [Melisi D] Digestive Molecular Clinical Oncology Research Unit, Department of Medicine, Università degli Studi di Verona, Verona, Veneto, Italy. [Westphalen CB] Department of Medicine III and Comprehensive Cancer Center Munich, University Hospital LMU Munich, Munich, Germany. [D'Esquermes N, Ferreras A] Genactis SAS, Mougins, France. [Macarulla T] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid31958291
dc.identifier.wos000527764500006
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Ficheros en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Regresa al Registro Simple